Skip to content
Viz-Aflibercept Pricing: A Case Study episode artwork

Mar 12, 2020 8 min

Viz-Aflibercept Pricing: A Case Study

from OncoPharm Hosted by John Bossaer

Looking back at a 2012 NYT op-ed (https://www.nytimes.com/2012/10/15/opinion/a-hospital-says-no-to-an-11000-a-month-cancer-drug.html) that led to a 50% price decrease in a biologic cancer medication.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Viz-Aflibercept Pricing: A Case Study

0:00 8:07

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OncoPharm?

This episode is 8 minutes long.

When was this OncoPharm episode published?

This episode was published on March 12, 2020.

Can I download this OncoPharm episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.